Position in OCUL
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$132,039
+$16,653 QoQ
Shares Held
13,446
-1.3% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#190
of 257 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,874,071,197 across 105 Biotechnology names. OCUL ranks #90 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in OCUL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $132,039 | 13,446 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $115,386 | 13,623 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $133,309 | 10,981 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $125,784 | 10,760 | Shares | Defined | 2025-11-04 | |
| 2025-03-31 | $92,526 | 12,623 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $114,606 | 13,420 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $126,680 | 14,561 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $180,329 | 26,364 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $253,707 | 27,880 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $97,936 | 21,959 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $69,302 | 22,071 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $114,789 | 22,246 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $120,529 | 22,871 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $69,030 | 24,566 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $83,393 | 20,095 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $82,695 | 20,571 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $69,473 | 14,035 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $90,860 | 13,036 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $1,457,410 | 145,741 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $2,058,935 | 145,200 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $484,570 | 29,529 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $628,555 | 30,365 | Shares | Defined | 2021-02-23 | |
| No filing history on record for this holder in this stock. | ||||||